Moreover, Hakai expression has also been studied in inflammatory bowel disease (IBD), which increases the risk of colorectal cancer (CRC) and includes conditions such as ulcerative colitis (UC) and Crohn’s disease (CD). This evidence concerns the gene CBLL1 and colorectal carcinoma.